Phase I Trial of Triapine–Cisplatin–Paclitaxel Chemotherapy for Advanced Stage or Metastatic Solid Tumor Cancers
Author:
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference34 articles.
1. Elevated ribonucleotide reductase levels associate with suppressed radiochemotherapy response in human cervical cancers;Kunos;Int J Gynecol Cancer,2012
2. Ribonucleotide reductase expression in cervical cancer: a radiation therapy oncology group translational science analysis;Kunos;Int J Gynecol Cancer,2013
3. Phase II trial of bevacizumab in the treatment of persistent or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study;Monk;J Clin Oncol,2009
4. Improved survival with bevacizumab in advanced cervical cancer;Tewari;N Engl J Med,2014
5. Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study;Rose;J Clin Oncol,1999
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Copper(II) Complexes with Isomeric Morpholine-Substituted 2-Formylpyridine Thiosemicarbazone Hybrids as Potential Anticancer Drugs Inhibiting Both Ribonucleotide Reductase and Tubulin Polymerization: The Morpholine Position Matters;Journal of Medicinal Chemistry;2024-05-21
2. Conjugated linoleic acid strengthens the apoptotic effect of cisplatin in A549 cells;Prostaglandins & Other Lipid Mediators;2023-06
3. RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition;Science Advances;2022-07-15
4. Sphingosine-1-phosphate transporter spinster homolog 2 is essential for iron-regulated metastasis of hepatocellular carcinoma;Molecular Therapy;2022-02
5. Modulation of Intracellular Copper Levels as the Mechanism of Action of Anticancer Copper Complexes: Clinical Relevance;Biomedicines;2021-07-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3